Search Results - "Vidailhet, P."

Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks? by El-Hage, W, Hingray, C, Lemogne, C, Yrondi, A, Brunault, P, Bienvenu, T, Etain, B, Paquet, C, Gohier, B, Bennabi, D, Birmes, P, Sauvaget, A, Fakra, E, Prieto, N, Bulteau, S, Vidailhet, P, Camus, V, Leboyer, M, Krebs, M-O, Aouizerate, B

“…The coronavirus disease 2019 (COVID-19) pandemic has caused major sanitary crisis worldwide. Half of the world has been placed in quarantine. In France, this…”
Get more information

First-episode psychosis, cognitive difficulties and remediation by Vidailhet, P

“…Cognitive difficulties are a core feature of schizophrenia. They are frequent, severe, and clearly associated with functional disabilities. They have been…”
Get more information

Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort by Andrianarisoa, M, Boyer, L, Godin, O, Brunel, L, Bulzacka, E, Aouizerate, B, Berna, F, Capdevielle, D, Dorey, J.M, Dubertret, C, Dubreucq, J, Faget, C, Gabayet, F, Llorca, P.M, Mallet, J, Misdrahi, D, Rey, R, Richieri, R, Passerieux, C, Schandrin, A, Tronche, A.M, Urbach, M, Vidailhet, P, Schürhoff, F, Fond, G

“…Abstract Objectives Depression and negative symptoms have been associated with impaired Quality of life (QoL) in schizophrenia (SZ). However, childhood trauma…”
Get full text

Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort by Fond, G., Godin, O., Schürhoff, F., Berna, F., André, M., Aouizerate, B., Capdevielle, D., Chereau, I., D’ Amato, T., Dubertret, C., Dubreucq, J., Faget, C., Lançon, C., Leignier, S., Mallet, J., Misdrahi, D., Passerieux, C., Pignon, B., Rey, R., Szoke, A., Urbach, M., Vidailhet, P., Leboyer, M., Boyer, L., Llorca, P.M.

“…The National FondaMental Centers of Expertise (FACE) for Schizophrenia (SZ) have been created to shorten the gap between research and clinical practice. To…”
Get full text

Changer de paradigme physiopathologique : schizophrénie et vitamine D by Vidailhet, P

Get full text

Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort by Fond, G., Bulzacka, E., Boucekine, M., Schürhoff, F., Berna, F., Godin, O., Aouizerate, B., Capdevielle, D., Chereau, I., D'Amato, T., Dubertret, C., Dubreucq, J., Faget, C., Leignier, S., Lançon, C., Mallet, J., Misdrahi, D., Passerieux, C., Rey, R., Schandrin, A., Urbach, M., Vidailhet, P., Leboyer, M., Boyer, L., Llorca, P.M.

“…Predicting psychotic relapse is one of the major challenges in the daily care of schizophrenia. To determine the predictors of psychotic relapse and follow-up…”
Get full text

Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohort by Fond, G., Godin, O., Dumontaud, M., Faget, C., Schürhoff, F., Berna, F., Aouizerate, B., Capdevielle, D., Chereau, I., D'Amato, T., Dubertret, C., Dubreucq, J., Leignier, S., Mallet, J., Misdrahi, D., Passerieux, C., Rey, R., Schandrin, A., Szoke, A., Urbach, M., Vidailhet, P., Leboyer, M., Lançon, C., Boyer, L., Llorca, P.M.

“…Sexual dysfunctions (SD) are frequent in schizophrenia (SZ) and associated with treatment withdrawal, however they remain under-explored and under-treated. To…”
Get full text

Recommendations of the schizophrenia expert center network for the screening prevention and treatment of sleep disorders based on the results from the real-world schizophrenia FACE-SZ national cohort by Sunhary de Verville, P.L., Etchecopar-Etchart, D., Richieri, R., Godin, O., Schürhoff, F., Berna, F., Aouizerate, B., Capdevielle, D., Chereau, I., D'Amato, T., Dubertret, C., Dubreucq, J., Leignier, S., Mallet, J., Misdrahi, D., Passerieux, C., Pignon, B., Rey, R., Urbach, M., Vidailhet, P., Leboyer, M., Llorca, P.M., Lançon, C., Boyer, L., Fond, G.

“…Sleep disorders associated factors are under explored in schizophrenia while the literature suggests high and heterogeneous frequency. The objective of the…”
Get full text

Major depression, sleep, hostility and body mass index are associated with impaired quality of life in schizophrenia. Results from the FACE-SZ cohort by Fond, G., Korchia, T., Sunhary de Verville, P.L., Godin, O., Schürhoff, F., Berna, F., André, M., Aouizerate, B., Capdevielle, D., Chereau, I., D'Amato, T., Dubertret, C., Dubreucq, J., Leignier, S., Mallet, J., Misdrahi, D., Passerieux, C., Pignon, B., Rey, R., Szoke, A., Urbach, M., Vidailhet, P., Leboyer, M., Llorca, P.M., Lançon, C., Boyer, L.

“…•Quality of life (QoL) is deeply impaired in schizophrenia (SZ) and is associated with poor prognosis.•559 subjects were included in the national FACE-SZ…”
Get full text

Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort by Mallet, J., Le Strat, Y., Schürhoff, F., Mazer, N., Portalier, C., Andrianarisoa, M., Aouizerate, B., Berna, F., Brunel, L., Capdevielle, D., Chereau, I., D'Amato, T., Denizot, H., Dubreucq, J., Faget, C., Gabayet, F., Lançon, C., Llorca, P.M., Misdrahi, D., Rey, R., Roux, P., Schandrin, A., Urbach, M., Vidailhet, P., Fond, G., Dubertret, C., Andrianarisoa, M., Aouizerate, B., Bazin, N., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, J.M., D'Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Ramet, L., Rey, R., Roman, C., Schandrin, A., Schürhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A.

“…Tobacco use is common in patients with schizophrenia (SZ) but little is known on the role of tobacco in the physiopathology or on the course of the disease…”
Get full text

Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort by Fond, G., Resseguier, N., Schürhoff, F., Godin, O., Andrianarisoa, M., Brunel, L., Bulzacka, E., Aouizerate, B., Berna, F., Capdevielle, D., Chereau, I., D’Amato, T., Dubertret, C., Dubreucq, J., Faget, C., Gabayet, F., Lançon, C., Llorca, P. M., Mallet, J., Misdrahi, D., Passerieux, C., Rey, R., Schandrin, A., Urbach, M., Vidailhet, P., Boyer, L., Leboyer, M.

“…Low-grade inflammation has repeatedly been associated with schizophrenia (SZ) and in particular with cognitive impairment. Female gender, overweight and…”
Get full text

Depressive recurrence: cognitive alterations and neuroplasticity by Vidailhet, P

“…The risk of recurrence in depression is high. It increases with the number of previous episodes while the triggering role of stressful life events…”
Get more information

Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohort by Fond, G, Godin, O, Schürhoff, F, Berna, F, Bulzacka, E, Andrianarisoa, M, Brunel, L, Aouizerate, B, Capdevielle, D, Chereau, I, Coulon, N, D'Amato, T, Dubertret, C, Dubreucq, J, Faget, C, Lançon, C, Leignier, S, Mallet, J, Misdrahi, D, Passerieux, C, Rey, R, Schandrin, A, Urbach, M, Vidailhet, P, Leboyer, M, Boyer, L, Llorca, PM

“…•Beyond its role in bone metabolism, vitamin D has been shown to have multiple functions including a role in depression and cognitive impairment in general…”
Get full text

Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset by Berna, F, Misdrahi, D, Boyer, L, Aouizerate, B, Brunel, L, Capdevielle, D, Chereau, I, Danion, J.M, Dorey, J.M, Dubertret, C, Dubreucq, J, Faget, C, Gabayet, F, Lancon, C, Mallet, J, Rey, R, Passerieux, C, Schandrin, A, Schurhoff, F, Tronche, A.M, Urbach, M, Vidailhet, P, Llorca, P.M, Fond, G

“…AbstractThe main objective of this study was to determine the prevalence of akathisia in a community-dwelling sample of patients with schizophrenia, and to…”
Get full text

Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ dataset by Fond, G., Boyer, L., Andrianarisoa, M., Godin, O., Brunel, L., Bulzacka, E., Coulon, N., Llorca, P.M., Berna, F., Aouizerate, B., Capdevielle, D., D'Amato, T., Dubertret, C., Dubreucq, J., Faget, C., Gabayet, F., Mallet, J., Misdrahi, D., Rey, R., Richieri, R., Roux, P., Passerieux, C., Schandrin, A., Tronche, A.M., Vidailhet, P., Leboyer, M., Schürhoff, F., Andrianarisoa, M., Aouizerate, B., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, J.M., D'Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Hardy-Bayle, M.C., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, P.M., Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Rey, R., Roman, C., Sebilleau, M., Schandrin, A., Schurhoff, F., Tessier, A., Tronche, A.M., Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A.

“…Reducing the duration of untreated psychosis (DUP) may improve the prognosis of schizophrenia. This study investigated the prevalence, and associated risk…”
Get full text

Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohort by Fond, G., Godin, O., Schürhoff, F., Berna, F., Aouizerate, B., Capdevielle, D., Chereau, I., D'Amato, T., Dubertret, C., Dubreucq, J., Faget, C., Leignier, S., Lançon, C., Mallet, J., Marulaz, L., Misdrahi, D., Passerieux, C., Rey, R., Schandrin, A., Urbach, M., Vidailhet, P., Leboyer, M., Boyer, L., Llorca, P.M.

“…•Major depression is a therapeutic challenge in schizophrenia.•Untangling different forms of major depression appears as the best current strategy to improve…”
Get full text

Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort by Fond, G., Berna, F., Andrianarisoa, M., Godin, O., Leboyer, M., Brunel, L., Aouizerate, B., Capdevielle, D., Chereau, I., D’Amato, T., Denizot, H., Dubertret, C., Dubreucq, J., Faget, C., Gabayet, F., Llorca, P. M., Mallet, J., Misdrahi, D., Passerieux, C., Richieri, R., Rey, R., Schandrin, A., Urbach, M., Vidailhet, P., Boyer, L., Schürhoff, F.

“…Chronic peripheral inflammation (CPI) has been associated with cognitive impairment in schizophrenia (SZ). However, its sources remain unclear, more…”
Get full text

Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort by Godin, O, Leboyer, M, Schürhoff, F, Boyer, L, Andrianarisoa, M, Brunel, L, Bulzacka, E, Aouizerate, B, Berna, F, Capdevielle, D, D'Amato, T, Denizot, H, Dubertret, C, Dubreucq, J, Faget, C, Gabayet, F, Llorca, P.M, Mallet, J, Misdrahi, D, Passerieux, C, Rey, R, Richieri, R, Schandrin, A, Urbach, M, Vidailhet, P, Costagliola, D, Fond, G

“…Abstract Metabolic syndrome (MetS) is highly prevalent in schizophrenia. However very little is known about the time course of MetS and its components. The few…”
Get full text

Influence of Venus and Mars in the cognitive sky of schizophrenia. Results from the first-step national FACE-SZ cohort by Fond, G., Boyer, L., Leboyer, M., Godin, O., Llorca, P.M., Andrianarisoa, M., Berna, F., Brunel, L., Aouizerate, B., Capdevielle, D., Chereau, I., D'Amato, T., Dubertret, C., Dubreucq, J., Faget, C., Gabayet, F., Mallet, J., Misdrahi, D., Rey, R., Lancon, C., Passerieux, C., Roux, P., Vidailhet, P., Yazbek, H., Schürhoff, F., Bulzacka, E., Andrianarisoa, M., Aouizerate, B., Berna, F., Blanc, O., Brunel, L., Bulzacka, E., Capdevielle, D., Chereau-Boudet, I., Chesnoy-Servanin, G., Danion, Jm, D'Amato, T., Deloge, A., Delorme, C., Denizot, H., Dorey, J.M., Dubertret, C., Dubreucq, J., Faget, C., Fluttaz, C., Fond, G., Fonteneau, S., Gabayet, F., Giraud-Baro, E., Hardy-Bayle, M.C., Lacelle, D., Lançon, C., Laouamri, H., Leboyer, M., Le Gloahec, T., Le Strat, Y., Llorca, Mallet, J., Metairie, E., Misdrahi, D., Offerlin-Meyer, I., Passerieux, C., Peri, P., Pires, S., Portalier, C., Rey, R., Roman, C., Sebilleau, M., Schandrin, A., Schurhoff, F., Tessier, A., Tronche, Am, Urbach, M., Vaillant, F., Vehier, A., Vidailhet, P., Vilà, E., Yazbek, H., Zinetti-Bertschy, A.

“…Sex differences can yield important clues regarding illness pathophysiology and its treatment. Schizophrenia (SZ) has a lower incidence rate, and a better…”
Get full text

The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice by Schürhoff, F, Fond, G, Berna, F, Bulzacka, E, Godin, O, Boyer, L, Misdrahi, D, Andrianarisoa, M, Brunel, L, Coulon, N, Aouizerate, B, Capdevielle, D, Chereau, I, D'Amato, T, Dubertret, C, Dubreucq, J, Faget, C, Gabayet, F, Mallet, J, Rey, R, Lancon, C, Passerieux, C, Schandrin, A, Urbach, M, Vidailhet, P, Leboyer, M, Llorca, P M

“…The present article is a synthesis of the first 10 years of follow-up of the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ) cohort. More…”
Get more information